Rule 29c is part of the State of Israel Pharmacy Regulations (Preparations) 1986, and is a specific, individual permit to import a drug that is not registered in the State of Israel for the purpose of using it as part of medical treatment or, alternatively, for permission to use a registered drug in a previously unregistered form.
Novel cannabis products and delivery system for improved bio-availability, accuracy, consistency and efficacy that can be proven and backed up with a strong IP and clinical trials
Conceptual & detailed design including personnel/material flow diagram, pressure cascade, cleanness level, utilities and technology based on current GxP standards and common practices
An effective quality management system establishment, policies and SOPs writing, cultivation and manufacturing procedures, protocols and employees training
Utilities, systems, machinery and controls required for cultivation, development and manufacturing processes that will enable high quality, control and cost-effectiveness.
Cannabis products specifications and regulatory requirements completion including all relevant documentation and data in order to be submitted and sold in regulatory markets
New facility, infrastructure, utilities, system, machinery, software, control system, manufacturing/cleaning processes qualification and validation protocols, execution and reports
חשיבות ה- Data integrity בחברות תרופות אמינות ושלמות הנתונים, או במונח הלועזי Data integrity מאפשרת הן לחברה והן לגופי [...]
New mRNA-based drugs platforms for cancer treatment The successful development of mRNA (messenger ribonucleic acid) based on anti-COVID 19 [...]
The medical and pharmaceutical industries are involved in new product development and manufacturing of medicines, medicinal products, biological products, [...]
Subscribe to our cool newsletter.
